v3.25.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Shares
Pre-funded warrants
Additional paid-in capital
Accumulated deficit
Total
Opening balance at Dec. 31, 2023 $ 260,504 $ 48,459 $ 33,834 $ (326,026) $ 16,771
Beginning Balance (in shares) at Dec. 31, 2023 33,483,111 9,577,257      
Increase (Decrease) in Stockholders' Equity          
Net loss       (10,354) (10,354)
Exercise of stock options $ 117       117
Exercise of stock options (in shares) 95,387        
Pre-funded warrants - Private Placement, net of issuance costs   $ 4,617     4,617
Pre-funded warrants - Private Placement, net of issuance costs (in shares)   3,333,333      
Share-based compensation     1,512   1,512
Issuance of common shares, net of issuance costs $ 27,258       27,258
Issuance of common shares, net of issuance costs (shares) 19,666,667        
Closing balance at Mar. 31, 2024 $ 287,879 $ 53,076 35,346 (336,380) 39,921
Ending Balance (in shares) at Mar. 31, 2024 53,245,165 12,910,590      
Opening balance at Dec. 31, 2024 $ 288,048 $ 53,076 39,568 (367,545) $ 13,147
Beginning Balance, warrants (in shares) at Dec. 31, 2024         12,910,590
Beginning Balance (in shares) at Dec. 31, 2024 53,353,984 12,910,590     53,353,984
Increase (Decrease) in Stockholders' Equity          
Net loss       (20,761) $ (20,761)
Share-based compensation     1,351   1,351
Employee stock purchase plan purchases $ 140       140
Employee stock purchase plan purchases (in shares) 110,289        
Closing balance at Mar. 31, 2025 $ 288,188 $ 53,076 $ 40,919 $ (388,306) $ (6,123)
Ending Balance, warrants (in shares) at Mar. 31, 2025         12,910,590
Ending Balance (in shares) at Mar. 31, 2025 53,464,273 12,910,590     53,464,273